Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Sell
48,505
-4,865
-9% -$130K 0.07% 120
2025
Q4
$1.33M Sell
53,370
-602
-1% -$15.2K 0.07% 117
2025
Q3
$1.38M Sell
53,972
-5,248
-9% -$130K 0.07% 114
2025
Q2
$1.44M Sell
59,220
-6,493
-10% -$151K 0.08% 111
2025
Q1
$1.67M Sell
65,713
-3,222
-5% -$84.3K 0.1% 102
2024
Q4
$1.83M Sell
68,935
-7,704
-10% -$209K 0.1% 98
2024
Q3
$2.22M Sell
76,639
-11,132
-13% -$325K 0.13% 92
2024
Q2
$2.46M Sell
87,771
-41,452
-32% -$1.14M 0.14% 81
2024
Q1
$3.59M Sell
129,223
-6,440
-5% -$179K 0.21% 66
2023
Q4
$3.91M Buy
135,663
+6,676
+5% +$202K 0.24% 59
2023
Q3
$4.28M Sell
128,987
-251
-0.2% -$8.88K 0.29% 53
2023
Q2
$4.74M Buy
129,238
+10,453
+9% +$407K 0.31% 50
2023
Q1
$4.85M Sell
118,785
-443
-0.4% -$19.1K 0.32% 45
2022
Q4
$6.11M Buy
119,228
+765
+0.6% +$36.7K 0.4% 36
2022
Q3
$5.18M Buy
118,463
+956
+0.8% +$46.5K 0.38% 38
2022
Q2
$6.16M Sell
117,507
-893
-0.8% -$45.5K 0.44% 36
2022
Q1
$6.13M Buy
118,400
+407
+0.3% +$21.1K 0.38% 38
2021
Q4
$6.97M Sell
117,993
-2,022
-2% -$100K 0.41% 36
2021
Q3
$5.16M Sell
120,015
-1,346
-1% -$59.6K 0.33% 44
2021
Q2
$4.75M Sell
121,361
-1,199
-1% -$46.6K 0.3% 49
2021
Q1
$4.44M Sell
122,560
-18,746
-13% -$666K 0.29% 49
2020
Q4
$5.2M Sell
141,306
-401
-0.3% -$14.7K 0.38% 42
2020
Q3
$4.93M Sell
141,707
-14,039
-9% -$492K 0.42% 40
2020
Q2
$4.83M Sell
155,746
-4,852
-3% -$165K 0.42% 41
2020
Q1
$4.97M Buy
160,598
+9,777
+6% +$333K 0.5% 36
2019
Q4
$5.61M Buy
150,821
+4,125
+3% +$147K 0.42% 39
2019
Q3
$5M Sell
146,696
-2,303
-2% -$83.7K 0.41% 43
2019
Q2
$6.12M Sell
148,999
-1,214
-0.8% -$48.2K 0.5% 37
2019
Q1
$6.05M Buy
150,213
+2,145
+1% +$85.9K 0.52% 38
2018
Q4
$6.13M Sell
148,068
-1,931
-1% -$80.2K 0.6% 31
2018
Q3
$6.27M Sell
149,999
-2,379
-2% -$91.6K 0.5% 36
2018
Q2
$5.25M Sell
152,378
-4,058
-3% -$139K 0.43% 39
2018
Q1
$5.27M Buy
156,436
+1,463
+0.9% +$50.3K 0.44% 37
2017
Q4
$5.33M Sell
154,973
-4,576
-3% -$156K 0.44% 38
2017
Q3
$5.4M Sell
159,549
-7,332
-4% -$236K 0.45% 36
2017
Q2
$5.32M Buy
166,881
+431
+0.3% +$13.6K 0.46% 37
2017
Q1
$5.4M Sell
166,450
-641
-0.4% -$20.2K 0.48% 34
2016
Q4
$5.15M Sell
167,091
-3,359
-2% -$103K 0.49% 36
2016
Q3
$5.48M Buy
170,450
+2,382
+1% +$79.6K 0.58% 30
2016
Q2
$5.61M Sell
168,068
-4,525
-3% -$144K 0.63% 31
2016
Q1
$4.85M Sell
172,593
-1,718
-1% -$49.1K 0.54% 38
2015
Q4
$5.34M Sell
174,311
-6,380
-4% -$201K 0.62% 36
2015
Q3
$5.38M Buy
180,691
+9,299
+5% +$298K 0.62% 31
2015
Q2
$5.45M Sell
171,392
-1,616
-0.9% -$52.7K 0.59% 33
2015
Q1
$5.71M Sell
173,008
-5,080
-3% -$162K 0.68% 33
2014
Q4
$5.26M Sell
178,088
-2,361
-1% -$67.7K 0.63% 35
2014
Q3
$5.06M Sell
180,449
-6,183
-3% -$174K 0.67% 33
2014
Q2
$5.25M Buy
186,632
+5,651
+3% +$161K 0.68% 35
2014
Q1
$5.51M Sell
180,981
-2,617
-1% -$78K 0.74% 30
2013
Q4
$5.33M Sell
183,598
-8,428
-4% -$245K 0.72% 29
2013
Q3
$5.23M Buy
192,026
+5,317
+3% +$145K 0.78% 26
2013
Q2
$4.96M Buy
+186,709
New +$5.16M 0.84% 23

Other funds holding PFE

1ST Source Bank's PFE Position: Q1 2026 in Review

1ST Source Bank reduced its Pfizer (PFE) stake by 9.1% in Q1 2026, selling an estimated $130K and leaving 48,505 shares worth $1.36M. The position accounts for 0.07% of the portfolio, ranked #120.

1ST Source Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.97M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • 1ST Source Bank held 48,505 shares of Pfizer worth $1.36M as of Q1 2026.
  • 1ST Source Bank sold 4,865 Pfizer shares in Q1 2026, an estimated $130K.
  • Pfizer made up 0.07% of 1ST Source Bank's portfolio in Q1 2026, its #120 holding.
  • 1ST Source Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • 1ST Source Bank's Pfizer position peaked at $6.97M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on 1ST Source Bank's 13F filing for Q1 2026, filed 4 May 2026.